FORMULATIONS PHARMACEUTIQUES : SELS DE 8-[{1-(3,5-BIS (TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE ET METHODES DE TRAITEMENT UTILISANT LESDITSSELS
Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1R)-1- (3,5-Bis-trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7- diazaspiro[4.5]decan-2-one,represented by Formula I, are disclosed. Disclosed also are methods oftreatmentutilizing such dosage forms.